| AD | Alzheimer’s disease |
| AKT | protein kinase B (PKB) |
| AP-1 | activator protein-1 |
| ATP | adenosine triphosphate |
| BDNF | brain-derived neurotrophic factor |
| COX | cyclooxygenase |
| CNS | central nervous system |
| ERK | extracellular signal-regulated kinase |
| GDNF | glial-derived neurotrophic factor |
| GFAP | glial fibrillary acidic protein |
| GSK-3 | glycogen synthase kinase-3 |
| HD | Huntington’s disease |
| HO-1 | hemoxygenase-1 |
| IFN-γ | interferon-γ |
| IL | interleukin |
| iNOS | inducible NO synthase |
| JAK/STAT | janus kinase/signal transducer and activator of transcription |
| JNK | c-Jun N-terminal kinase |
| LPS | lipopolysaccharide |
| MAPK | mitogen-activated protein kinase |
| M2 | anti-inflammatory microglial phenotype |
| MCP-1 | monocyte chemoattractant protein-1 |
| MS | multiple sclerosis |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP | nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain, |
| NO | nitric oxide |
| NOS | NO synthase |
| NPY | neuropeptide Y |
| Nrf-2 | nuclear factor erythroid 2-related factor 2 |
| PGE2 | prostaglandin E2 |
| PI3K/AKT | phosphatidylinositol-3 kinase/protein kinase B |
| PD | Parkinson’s disease |
| PKB | protein kinase B (AKT) |
| PPAR-γ | proliferator-activated receptor γ |
| PRR | pattern recognition receptor |
| TGF-β | transforming growth factor β |
| TLR | toll-like receptor |
| TNF-α | tumor necrosis factor-α |
| TNFR | tumor necrosis factor receptor |
| TRADD | TNFR1 signal transducer |
| TRAF | TNFR-associated factor |
| VEGF | vascular endothelial growth factor |